ByteSeed related personnel respond to rumors of Gu Quanquan's departure: not responsible for AI pharmaceuticals or pre-training.

Interface News reporters interviewed Byte Seed related personnel. The person said, "Gu Quanquan has participated in some work on biological molecular structure prediction and LLM pretraining within the company, but is not responsible for the AI pharmaceutical and pretraining at Byte Seed, and is not familiar with its entrepreneurial matters."